Robin Gabel

Q: What is Robin L Gabel email address?

Email Robin L Gabel at rlg0126@gmail.com and robin.gabel@bristol.com.br. This email is the most updated Robin L Gabel's email found in 2026.

Q: How to contact Robin L Gabel?

To contact Robin L Gabel send an email to rlg0126@gmail.com or robin.gabel@bristol.com.br. (updated on September 02, 2024)

Executive Immuno-Oncology Specialist at Bristol-Myers Squibb | Greater Philadelphia

About Robin Gabel

Robin L. Gabel serves as an Executive Immuno-Oncology Specialist at Bristol-Myers Squibb, where she leverages her extensive, award-winning experience to drive the successful launch and sales of pivotal immuno-oncology agents, including Opdivo and Yervoy. With a focus on treating complex conditions such as Non-Small Cell Lung Cancer, Renal Cell Carcinoma, and Metastatic Melanoma, Robin plays a critical role in the Greater Philadelphia area, ensuring that healthcare providers have access to cutting-edge therapies that can significantly improve patient outcomes.

In her current role, Robin is not only responsible for the launches of new indications but also for the strategic execution of sales initiatives that align with the company's broader goals. Her expertise in the buy-and-bill model and sales operations allows her to effectively navigate the complexities of the healthcare landscape, ensuring that both new and existing accounts are managed with a sense of urgency and precision. As a trusted advisor, she cultivates strong relationships with key opinion leaders (KOLs) and healthcare professionals, providing them with a thorough understanding of the products and their clinical applications.

Robin's commitment to excellence is evident in her ability to develop comprehensive business plans that drive growth and enhance market penetration. Her skills extend across various therapeutic areas, including cardiology and allergy, making her a versatile asset within the organization. As part of a matrix team, she collaborates with cross-functional partners to ensure that Bristol-Myers Squibb remains at the forefront of innovation in immuno-oncology, ultimately contributing to the advancement of cancer treatment and improving the lives of patients.

Robin Gabel Work